Articles tagged with Inflammation
Researchers found that difficult patients distract doctors from processing clinical information correctly, leading to higher misdiagnosis rates. The study showed that even with more time spent on diagnosis, doctors were still more likely to misdiagnose difficult patients than neutral ones.
A study found that subcutaneous insulin infusion does not prevent oxidative stress and inflammation in the liver, despite reducing glycemic variability. The therapy also failed to preserve balance of anti- and pro-oxidant species.
A recent study suggests that immunotherapy can improve cognitive ability in patients with schizophrenia by suppressing inflammation. The study found significant improvements in cognitive function after just two doses of an immune-suppressing drug, tocilizumab.
Macrophages produce excess inflammatory cytokine IL-1beta when damaged mitochondria release signals; p62 coats damaged mitochondria, ensuring removal. This prevents chronic inflammation and potentially age-related diseases.
Researchers found that ceria nanoparticles can reduce inflammation in the brain following a bleeding stroke by decreasing the secretion of inflammatory chemicals. In a lab experiment, macrophages treated with ceria nanoparticles showed less damage and water accumulation at the stroke site compared to untreated cells.
Researchers found that aerobic fitness protected against metabolic dysfunction in the liver, reducing inflammation and fatty deposits. Chronic alcohol ingestion did not cause significant changes in blood insulin or glucose levels, contrary to expectations.
A study of over 287,000 patients found that African-American patients with connective tissue diseases like lupus and rheumatoid arthritis were twice as likely to develop narrowed or atherosclerotic blood vessels. Young African-Americans with CTD also had a higher risk of cardiovascular disease, including heart attacks and strokes.
Researchers at NIH/NIEHS discovered that increasing tristetraprolin (TTP) levels in mice significantly reduced or protected against inflammation. TTP may offer an effective treatment for inflammatory diseases such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
A study published in Genes & Development found that inhibiting the MLL1 enzyme prevents age-related inflammation and cancer. Researchers discovered that MLL1 is critical for regulating gene expression and is commonly mutated in human cancers, leading to increased inflammation and tissue degeneration.
Dasatinib, a cancer treatment, reduces inflammation and improves lung mechanics in mice with allergic asthma. The drug targets tyrosine kinases involved in asthma's signaling pathways.
Researchers have found a link between the chickenpox and shingles vaccine and corneal inflammation in rare instances. Primary care physicians should discuss this potential side effect with susceptible patients before vaccination.
Researchers at the University of Edinburgh have identified a chemical compound that blocks KMO, fueling inflammation linked to acute pancreatitis. The approach calms inflammation in the condition and protects against organ failure, offering hope for patients with life-threatening complications.
The study found that microglia, the brain's immune system, rapidly repair damage to the blood-brain barrier after breaches. This process could be impaired by certain cardiovascular drugs intended to prevent stroke-related damage.
Scientists at Augusta University found that YAP helps control astrocyte function, regulating the protective blood-brain barrier. Without YAP, astrocytes become hyper-reactive, leading to deadly inflammation and potential hydrocephalus.
Researchers at Oxford University are exploring the link between metabolism and inflammation in metabolic diseases, including type 2 diabetes and cardiovascular disease. The projects aim to deliver effective treatments and prevention strategies, addressing a global health problem affecting over 400 million people worldwide.
A rapid molecular assay using RNA biomarkers in blood can differentiate sepsis from infection-negative systemic inflammation more accurately and quickly than traditional methods. The assay, known as SeptiCyte Lab, was validated in independent cohorts and showed high sensitivity and specificity.
A consensus report by Mayo Clinic researchers provides a standardized approach to diagnosing glomerulonephritis based on the underlying cause of the disease. This new method aims to improve personalized diagnosis and targeted treatment for patients with kidney disease.
Researchers at Boston University School of Medicine have identified Th17 cells and Th1 as key players in obesity-associated type 2 diabetes. The study reveals a biomarker that can predict the development of Type 2 diabetes in 75% of people with obesity, offering new potential targets for prevention.
Research suggests that healthy cells are optimized for a healthy ecosystem; changes in this ecosystem allow cancer-causing mutations to outcompete healthy rivals, leading to an increase in cancerous cells. Inflammation is a critical factor in this process, hurting the growth and maintenance of healthy B-cell progenitor cells.
A new study published in Biological Psychiatry found that treatment for insomnia with cognitive behavioral therapy or tai chi reduces inflammation levels in older adults. These behavioral interventions also represent a third pillar, along with diet and physical activity, to promote health and reduce age-related morbidities.
Researchers at LSU have identified a new gene regulation pathway that prevents inflammation and speeds up the skin's healing process. A nanoparticle-carried small interference RNA blocks the Nax sodium sensor, enabling faster healing.
Researchers found that male mice recruit more white blood cells to the site of inflammation than females, highlighting the importance of sex differences in inflammatory responses. This discovery has implications for how we design and interpret experiments and evaluate anti-inflammatory therapeutics.
A recent study by Temple researchers found that a protein isolated from bacterial biofilms, known as curli, can effectively relieve intestinal inflammation in animals. The results suggest that curli could be a novel immunotherapy for inflammatory bowel disease, offering a new treatment option for patients.
A new study aims to determine the mechanisms that cause some grieving survivors to suffer unanticipated and potentially fatal heart attacks. The researcher hopes to understand how stress, depression, and anxiety contribute to inflammation, a driver of cardiovascular disease.
Researchers at Jena University developed a cellular system to study inflammation processes in real time, providing a method for targeting new therapeutic approaches. The system allowed them to clarify the exact regulatory mechanism of 5-LO and FLAP interaction, enabling tests for active compounds.
Researchers found that yoga exercises improve pulmonary function and exercise capacity comparable to traditional pulmonary rehabilitation methods. Yoga-based programs may be a cost-effective alternative for COPD management.
Researchers at Yale University have developed a synthetic process to synthesize glucosepane, a critical chemical link in both diabetes and aging. This breakthrough may lead to the development of tools to examine the role glucosepane plays in human health and potentially inhibit its formation.
Researchers have discovered a new molecule involved in the development of fibrosis, a condition characterized by inflammation and stiffening of skin tissue. High levels of this molecule, fibulin-5, were found to contribute to increased skin tissue inflammation and stiffening.
Researchers from Brigham and Women's Hospital discovered specialized pro-resolving mediators (SPMs) in human breast milk that resolve inflammation, stimulate immune response, and heal wounds. These findings suggest a critical role for SPMs in infant development and immune system maturation.
Researchers at Helmholtz Centre for Environmental Research (UFZ) discovered a protein called syndecan-4 that plays a critical role in developing allergic airway inflammation. The study found that syndecan-4 helps immune cells migrate to T-cells, initiating an immune reaction and sensitization to specific allergens.
A study from the Gladstone Institutes reveals that a single drop of blood in the brain can trigger an autoimmune response akin to multiple sclerosis. Fibrinogen, a blood-clotting factor, activates microglia and recruits peripheral immune cells, causing myelin damage and inflammation.
Research found that psoriasis patients had high levels of blood vessel inflammation, even at low cardiovascular risk. The most extensive forms of psoriasis were associated with a 51% increase in blood vessel inflammation.
A Georgia State University researcher is investigating the impact of emulsifiers on gut microbiota, leading to chronic inflammatory diseases and metabolic syndrome. The study aims to determine how emulsifiers alter the intestinal tract's relationship with beneficial bacteria.
A study from the University of Eastern Finland found that infrared thermography can detect joint inflammation in ankle joints, but not knee joints. The technique also showed potential in evaluating office ergonomics and assessing musculoskeletal conditions, which could ease the workload in specialized healthcare and reduce costs.
A University of Eastern Finland study found that long sleep duration is associated with high serum copper concentrations, potentially linking it to pro-oxidative stress and chronic diseases like coronary artery disease. This association remained unchanged even when cardiovascular diseases were accounted for.
Scientists at Queen's University Belfast have developed a novel anti-inflammatory nanoparticle that shows promise in treating sepsis and Acute Respiratory Distress Syndrome (ARDS), two leading causes of death in hospitalised patients. The treatment, known as SAN101, has the potential to reduce inflammation and prevent organ failure.
Scientists have identified a gene variant that slows Alzheimer's disease progression by preventing eotaxin levels from increasing with age. The study found that individuals carrying this variant experienced a modest delay in disease onset, suggesting a potential protective mechanism against the disease.
Researchers discovered MIF, a molecule involved in EoE, which can be targeted for therapy. The study suggests a novel approach to treating this hard-to-treat food allergy, offering hope for patients with difficulty swallowing.
Researchers at the University of Zurich have discovered that an overproduction of E. coli bacteria is triggered by the availability of sialic acid, leading to intestinal inflammation. A sialidase inhibitor can prevent excessive E. coli formation and alleviate disease symptoms.
A study of high-intensity interval training in women with rheumatic disease found significant reductions in arthritic inflammation and improvements in cardiovascular health. Participants experienced less inflammation, increased oxygen intake, and a small reduction in BMI after ten weeks of twice-weekly sessions.
Researchers have developed a dynamic 'smart' drug that targets inflammation in a site-specific manner, reducing side effects. The new anti-inflammatory molecule reduces local inflammation while avoiding normal inflammatory processes, potentially improving treatment outcomes for immunosuppressed patients and those undergoing chemotherapy.
Researchers found elevated cytokine levels in blood and brain of individuals with suicidality, distinguishing them from non-suicidal patients. This study contributes to understanding the role of immune system dysfunction in major psychiatric disorders, potentially leading to more personalized medicine.
Inflamed kidney cells produce an enzyme that consumes tryptophan, activating a stress response and inducing autophagy to clear damaged protein. The IDO-GCN2 pathway provides natural protection against inflammation-induced kidney damage, offering new potential treatment targets.
Researchers found that a lower dose of modified poliovirus therapy is more effective in treating glioblastoma brain tumors, resulting in fewer side effects. The therapy has been shown to be safe with minimal side effects related to localized brain inflammation.
As we age, our gut's immune system regulator IL-6 increases, leading to chronic low-grade inflammation and a weakened barrier, making us more susceptible to infections and diseases.
A new study suggests that Symprove, a live multi-strain probiotic drink, can reduce intestinal inflammation in patients with ulcerative colitis. The results show significant reductions in faecal calprotectin levels and improvements in symptoms without observed side effects.
Researchers at Case Western Reserve University found that treating gum disease can improve prostate inflammation symptoms and quality of life for men with prostatitis. The study, which treated 27 men with moderate to severe gum disease, showed significant improvements in PSA levels and symptom scores.
A UTMB study shows that augmenting a gas naturally in our bodies, hydrogen sulfide, can reduce the severity of respiratory syncytial virus (RSV) infection. The researchers found that providing a drug that triggers a steady release of this gas blocks RSV viral replication and inflammation.
Researchers have identified the calcium sensing receptor (CaSR) as the potential root cause of asthma, a disease affecting 300 million people globally. Calcilytics, originally developed for osteoporosis, show promise in reversing asthma symptoms by manipulating CaSR.
Researchers analyzed saliva of cirrhosis patients to predict inflammasions and hospitalization, revealing a new target for research. The study found that oral microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
The study found a significant association between periodontitis and cardiovascular disease, particularly among men and younger individuals. Researchers suggest that alternative therapies, such as cholesterol-lowering medication, may prevent both oral infections and cardiovascular inflammation.
A new study published in the American Journal of Pathology shows that inflammation plays a causal role in Lyme disease's neurologic changes, and anti-inflammatory drugs like dexamethasone may prevent these effects. Researchers found that dexamethasone prevented many neuropathologic effects, while meloxicam was generally ineffective.
A study led by researchers from Mount Sinai Hospital shows that a nanotherapeutic medicine can halt the growth of artery plaque cells and suppress inflammation, leading to reduced heart attack risk. The therapy uses high-density lipoprotein (HDL) to target inflamed immune cells in arterial plaques.
Researchers aim to improve stability of transplanted regulatory T cells using computational modeling and analysis. The goal is to develop new treatment options for diseases characterized by excessive inflammation.
Scientists at the University of Manchester discovered that inflammation in the brain causes and worsens damage after a stroke, contradicting previous theories. The study found that inflammasomes such as NLRP3 are not involved in brain injury caused by stroke, but rather NLRC4 and AIM2 inflammasomes contribute to this damage.
Scientists have discovered a combination of fullerene derivatives and glucosamine that reduces cell damage and inflammation after a stroke. This breakthrough could lead to the development of new treatments for cerebrovascular accidents.
Scientists have identified Interleukin 4 (IL-4) as a promising treatment for psoriasis, a chronic autoimmune disease. By inhibiting specific immune cells, IL-4 reduces inflammation and improves skin conditions in patients.
Researchers identify small molecules that program stem cells to target specific areas in the body. These compounds enable targeted delivery of stem cells to diseased or damaged tissue, reducing inflammation.
Emulsifiers found in processed foods can alter the gut microbiota composition and induce intestinal inflammation, promoting the development of inflammatory bowel disease and metabolic syndrome. The study suggests that avoiding excess food consumption is crucial, as low-grade inflammation from an altered microbiota can lead to overeating.
Researchers developed targeted biodegradable nano-drones that deliver an anti-inflammatory drug to fat deposits in arteries, successfully restructuring atherosclerotic plaques to make them more stable. The treatment reduced reactive oxygen species, increased collagen, and decreased plaque necrotic core.